QuidelOrtho Corporation (QDEL) News

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference

QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for...

Form 8-K - Current report

QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results

Strong finish to 2024 with continued progress in cost-savings initiatives to drive adjusted EBITDA margin expansion in 2025 and beyond Company...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024

Top-line Results In Line with Expectations; Company Expects to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025...

Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm

Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm PR Newswire NEW YORK, Jan. 7...

QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference

QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for...

Form 8-K - Current report